Dissolved and financials
CVR: 37768014
DKK -8,063
Gross profit
Net result: DKK -8,082
No owners listed
CVR · view owners
No current management
CVR · view management
Dissolved
Ceased 12 April 2023
CVR · view overview
0 employees
Annual report 2020 · average
Director role ended: Marianne Philip
CVR · 18/05/2022
View the full event history
Steimertaler IVS was a Danish company of the type Iværksætterselskab based in Nordhavn, founded in 2016. The company has been dissolved on 12 April 2023. The company was registered under the industry Ikke-finansielle holdingselskaber. According to the 2020 annual report, the company had an average of 0 employees. In 2020, the company reported a gross profit of DKK -8,063 and a net result of DKK -8,082 compared with DKK -7,830 the year before. Equity in the 2020 report amounted to DKK -39,455.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202001/01/2020 – 31/12/2020 | -8K | -8K | 97 | -39K | 0 | |
| 201901/01/2019 – 31/12/2019 | -8K | -8K | 97 | -31K | 0 | |
| 201801/01/2018 – 31/12/2018 | -8K | -8K | 97 | -24K | 1 | |
| 201701/01/2017 – 31/12/2017 | -8K | -8K | 97 | -16K | 1 |
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningNo. Steimertaler IVS is registered in the Danish CVR register with the status Dissolved and ceased on 12 April 2023.
The CVR number of Steimertaler IVS is 37768014.
In 2020, Steimertaler IVS reported a gross profit of DKK -8,063.
Steimertaler IVS had an average of 0 employees in the 2020 financial year according to the annual report.
Steimertaler IVS was founded on 2 June 2016.
Steimertaler IVS was registered under the industry Ikke-finansielle holdingselskaber (industry code 642020).
Steimertaler IVS was dissolved on April 12, 2023.
As of May 18, 2022, Marianne Philip has stepped down as liquidator of Steimertaler IVS.
On May 18, 2022, Steimertaler IVS exited liquidation.
As of February 22, 2022, Marianne Philip is registered as liquidator of Steimertaler IVS.
On February 22, 2022, Steimertaler IVS entered liquidation.
As of January 27, 2022, Ronald Patrick Frey has stepped down as director of Steimertaler IVS.
Steimertaler IVS has published its annual report for 2020. Gross profit came to DKK -8,063, and the net result was DKK -8,082.
Steimertaler IVS has published its annual report for 2019. Gross profit came to DKK -7,813, and the net result was DKK -7,830.
Steimertaler IVS has published its annual report for 2018. Gross profit came to DKK -8,013, and the net result was DKK -8,015.
Steimertaler IVS has published its annual report for 2017. Gross profit came to DKK -7,813, and the net result was DKK -7,813.
Steimertaler IVS has published its interim report for the period June 2, 2016 to December 31, 2016.
As of June 2, 2016, Ronald Patrick Frey is registered as director of Steimertaler IVS.
Steimertaler IVS was founded on June 2, 2016.

Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.

Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.

Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed

Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.

Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.